| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.003 |